Biohaven Ltd. (BHVN)
NYSE·Healthcare·Biotechnology
$13.60
+12.49%
Mkt Cap $1.19B
Analyst Ratings
Buy
7
Hold
3
Sell
0
Price Target (25 analysts)
$17.83
Range $10.00 – $26.00
Implied Upside
+31.1%
Consensus $17.83 vs current $13.60
NYSE·Healthcare·Biotechnology
$13.60
+12.49%
Mkt Cap $1.19B
Buy
7
Hold
3
Sell
0
Price Target (25 analysts)
$17.83
Range $10.00 – $26.00
+31.1%
Consensus $17.83 vs current $13.60